Skip to main content

Table 2 The World Health Organization Quality of Life (WHOQOL-BREF) after 12 months of anticoagulant treatment with warfarin and rivaroxaban in the patients with paroxysmal nocturnal haemoglobinuria

From: Antithrombotic therapy with rivaroxaban in five patients with paroxysmal nocturnal haemoglobinuria and thrombotic events

 

Pt

1

Pt

2

Pt

3

Pt

4

All patients (n = 4)

t-test

W

R

W

R

W

R

W

R

W

R

p

Total (26 items)

67

76

42

65

47

58

62

67

54.5 ± 11.9

66.5 ± 7.4

0.053

 QOL rate (1 item)

25

75

50

50

25

25

25

75

31.3 ± 12.5

56.3 ± 23.9

n. s.

 Satisfaction (1 item)

50

75

50

25

25

25

50

50

43.8 ± 12.5

43.8 ± 23.9

n. s.

 Physical (7 items)

64

71

29

54

32

50

46

61

42.8 ± 16.0

59.0 ± 9.2

0.022

 Psychological (6 items)

71

83

50

67

46

58

63

67

57.5 ± 11.6

68.8 ± 10.4

0.025

 Social relationships (3 items)

83

83

50

67

92

92

67

75

73.0 ± 18.5

79.3 ± 10.7

n. s.

 Environment (8 items)

69

72

44

81

50

59

78

72

60.3 ± 15.9

71.0 ± 9.1

n. s.

  1. W Warfarin treatment; R Rivaroxaban treatment. Statistical analysis was performed using Student’s t-test
  2. Significant level was set to p < 0.05. n. s. = not significant